RXO NYSE Week ended 31 Jul 2026

Weekly Investor Report

RXO Inc. · Industrials · Trucking

Open interactive chart View report data
Latest close 20.25 USD
-21.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 3.0% above the Trend Line and sits at 50.4% of its 52-week range. The latest completed week returned -21.0%, after a -23.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 49/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: earnings are due in 4d.

Setup score 45 out of 100
Latest Close 20.25 USD 31 Jul 2026
1W Return -21.0% latest completed week
4W Return -23.9% short-term follow-through
12W Return -6.9% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • The trend backdrop is active with a 15-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -21.0% Latest completed week; four-week move -23.9%. Indicator stack 66/53 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 49/100 conviction; expected move 21.9%. News sentiment 52/100 15 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.0% above the Trend Line and sits at 50.4% of its 52-week range. The latest completed week returned -21.0%, after a -23.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9512-week average 0.86

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.95Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -23.9% over four weeks, -6.9% over 12 weeks, and 35.0% over one year. The current trend has remained active for 15 consecutive weeks.

Performance by holding period

1W-21.0%
4W-23.9%
12W-6.9%
26W38.9%
52W35.0%
Active trend streak15 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.47Latest activity-pressure read.
Pressure change-66.5%Four-week change in activity pressure.
Leadership6.30Latest relative-leadership reading.
RS change-85.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength22/100Blend of value, momentum, and quality. Underlying universe rank 79; rank 1 is best.
Value28/100Relative valuation strength. Underlying universe rank 73; rank 1 is best.
Quality8/100Profitability and accounting quality. Underlying universe rank 93; rank 1 is best.
Momentum86/100Medium-term price momentum. Underlying universe rank 15; rank 1 is best.
Growth73/100Revenue and earnings growth. Underlying universe rank 28; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.7x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
17.1%
Gross profit retained from each unit of revenue.
Operating margin
-2.3%
Operating profit retained from revenue.
Free-cash-flow margin
1.9%
Free cash flow generated from revenue.
Return on invested capital
-4.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
13.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
282.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-32.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

RXO shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.16, expected move of 21.9%, and Sharemaestro trend signal active.

Conviction49/100
Expected move21.9%
Put/call volume0.16
Pressure61
Speculation9
Volatility92
Trend agreement46
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 15 relevant articles.

6 positive · 6 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move21.9%Nearest-chain priced movement where available.
52-week drawdown-32.3%Distance below the 52-week high.
13-week volatility13.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+30.4%Week of 22 May.
Worst week-21.0%Week of 31 Jul.
Latest week-21.0%Week of 31 Jul.

Shape of recent returns

Strong gains14
Modest gains3
Flat weeks0
Modest losses2
Sharp losses7
Recent vol13.0%13-week weekly-return volatility.
Base vol11.0%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew7.7% / -10.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape53/100

Trend, activity pressure, participation, and risk combine to a 53/100 tape read.

 Indicator analysis91/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.95; No reversal markers Factors33/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 66; Small Cap Core rank 76 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options48/100

RXO shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.16, expected move of 21.9%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 21.9% Sentiment52/100

Weighted news tone is neutral across 15 relevant articles.

Intrinsic Edge Capital Management LLC Makes New Investment in Rxo Inc $RXO Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202620.25 USD-21.0%19.66 USD20.33 USD0.476.3014.5MOn
24 Jul 202625.63 USD-12.5%19.41 USD20.33 USD0.8936.307.3MOn
17 Jul 202629.29 USD11.6%18.98 USD20.31 USD1.2255.6710.3MOn
10 Jul 202626.25 USD-1.4%18.46 USD20.25 USD1.2338.775.7MOn
3 Jul 202626.61 USD-1.9%18.10 USD20.22 USD1.4043.355.4MOn
26 Jun 202627.12 USD6.8%17.69 USD20.18 USD1.4550.2511.1MOn
19 Jun 202625.39 USD-10.4%17.23 USD20.16 USD1.4138.539.8MOn
12 Jun 202628.35 USD5.5%16.76 USD20.13 USD1.5157.1313.3MOn
5 Jun 202626.86 USD5.0%16.18 USD20.09 USD1.3651.188.3MOn
29 May 202625.58 USD5.0%15.70 USD20.06 USD1.4541.437.1MOn
22 May 202624.37 USD30.4%15.44 USD20.03 USD1.4337.4921.2MOn
15 May 202618.69 USD-14.1%15.21 USD20.01 USD1.336.9117.2MOn
8 May 202621.75 USD11.0%15.16 USD20.02 USD1.4024.2717.7MOn
1 May 202619.59 USD1.1%14.99 USD20.00 USD1.1714.898.2MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.